Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI Therapy [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of BL0020 injection for small cell lung cancer transformed from non-small cell lung c…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizumab in the Maintenance Treatment Period for Patients of Extensive-stage Small Cell Lung Cancer (ES-SCLC) With Somatostatin Receptors (SSTR)+ as First-line Treatment [Phase 1]
Phase I study evaluating the safety and preliminary efficacy of Actinium-225 DOTATATE in combination with tislelizumab as maintenance therap…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer [Phase 3]
BioNTech's investigational therapy BNT327, in combination with chemotherapy, is being studied in untreated extensive-stage small-cell lung c…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Sarcopenia and Cachexia in Patients With Lung Cancer
This clinical trial update indicates an ongoing study examining sarcopenia and cachexia in patients with lung cancer (both non-small cell an…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain [Phase 2]
An ongoing Phase 2 clinical trial is evaluating stereotactic radiosurgery for patients with lung cancer that has spread to the brain and is …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Anlotinib in Cross-line Treatment of NSCLC and SCLC
This clinical trial update shows that anlotinib is being evaluated for cross-line treatment of advanced non-small cell lung cancer and exten…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC) [Phase 2]
A multicenter Phase II randomized study evaluating adebrelimab in combination with chemotherapy and concurrent low-dose radiotherapy for ext…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors [Phase 1]
Phase 1 clinical trial update on the investigational agent BL-M14D1 for locally advanced or metastatic small cell lung cancer and a range of…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer [NA]
This entry reports a clinical trial evaluating YSQTG combined with immuno-chemotherapy for extensive-stage small cell lung cancer. The study…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC [Phase 2]
A Phase 2 trial is evaluating Niraparib in combination with anti-PD-L1 antibody maintenance for SLFN11-positive, extensive-stage small cell …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers [Phase 2]
A Phase 2 study (DAREON-5) is evaluating different doses of BI-764532 in people with small cell lung cancer and other neuroendocrine cancers…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of MGC026 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for MGC026 in participants with advanced solid tumors; study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer [EARLY_Phase 1]
This document reports an early-stage Phase 1 trial at UNC evaluating autologous CAR T-cells targeting the GD2 antigen for lung cancer, with …
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients [Phase 2]
A Phase 2 clinical trial is evaluating tarlatamab as maintenance therapy after chemo-radiotherapy in patients with limited-stage small cell …
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Lung Cancer Screening in Population Who Had Never Smoked [NA]
A clinical trial update describing a study on lung cancer screening in people who have never smoked; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction [Phase 2]
Phase II, prospective, single-arm trial evaluating irinotecan liposome injection with platinum, immune checkpoint inhibitors, and anlotinib …
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating BL-B01D1 in patients with metastatic or unresectable non-small cell lung cancer and other solid tumors is …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) [Phase 2]
A prospective, single-arm Phase II trial is evaluating the safety and efficacy of adding chidamide to a PD-L1 inhibitor, carboplatin, and et…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients [Phase 1]
Phase 1 study of NEUK203-13 in refractory neuroendocrine tumors and extensive-stage small cell lung cancer reports safety, tolerability and …
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial evaluating adverse events and disease activity changes with ABBV-706 versus standard of care in adults with relapse…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer [Phase 1, Phase 2]
IDEAYA Biosciences is conducting a Phase 1/2 trial of IDE849 in DLL3-expressing tumors, including small cell lung cancer and neuroendocrine …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating bemotuzumab with chemotherapy and anlotinib induction followed by consolidative thoracic radiotherapy for …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD [Phase 2]
This Phase 2 clinical trial investigates post-concurrent chemoradiotherapy treatment strategies for limited-stage small cell lung cancer gui…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients [NA]
A prospective, longitudinal biocollection in thoracic oncology enrolling newly diagnosed lung cancer patients to collect biological samples …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia
This AstraZeneca-sponsored clinical trial assesses chemo-radiation therapy patterns and short-term outcomes in routine practice for unresect…